Hardell 2013: 20 Years of Brain Tumor Data — What Long-Term Mobile Phone Use Actually Shows

Hardell 2013: 20 Years of Brain Tumor Data — What Long-Term Mobile Phone Use Actually Shows

By Aires Tech

EMF Research File — The Landmark Studies

Hardell 2013: 20 Years of Brain Tumor Data — What Long-Term Mobile Phone Use Actually Shows

Hardell L, Carlberg M, Hällquist A, et al., 2013 — Pathophysiology — Örebro University, Sweden

“The risk increased with latency time and cumulative use in hours and was highest in the group with 25+ years use of mobile phones.” — Hardell et al., 2013
Study type: Population-based case-control epidemiological study (pooled analysis across multiple studies 1997–2013)
Principal investigator: Lennart Hardell, MD, PhD, Oncologist, Örebro University Hospital, Sweden
Sample: 1,380 glioma cases + 1,416 controls; additional analysis of acoustic neuroma
Finding: Dose-dependent increased glioma risk with long-term mobile phone use, especially 25+ years
2.0×
Elevated glioma risk at 25+ years mobile phone use
Dose-resp.
Risk increased with cumulative hours of use
Ipsilateral
Highest risk on side of head where phone was held
25+ yrs
Longest latency group showed highest elevation

Why Long-Term Human Data Is Uniquely Valuable

Animal studies and in vitro experiments can be controlled and replicated, but they test surrogate endpoints in model systems. Epidemiological data in humans, despite its confounders, asks the question that ultimately matters: do people who use mobile phones more develop more brain tumors? The Hardell group has been pursuing this question longer than any other research group in the world — accumulating 20+ years of human data across multiple case-control studies pooled into increasingly powered analyses.

The Dose-Response Relationship

Risk increased with cumulative hours of use. The strongest finding is the dose-response relationship: the more hours of cumulative mobile phone use, the higher the glioma risk. This is the key epidemiological signal that separates association from probable causation. Random confounding does not typically produce dose-response relationships.
Highest risk at longest latency: 25+ years of use. In the subgroup with 25 or more years of mobile phone use, glioma risk was elevated approximately 2-fold. This is consistent with the known multi-decade latency periods of other environmental carcinogens — and with the fact that widespread mobile phone adoption only began in the 1990s, meaning the longest-latency data are only now becoming available.
Ipsilateral dominance: tumor on the phone-use side. Gliomas were significantly more common on the same side of the head as the patient reported using their phone. This anatomical specificity is difficult to explain as recall bias or random chance. It is the same ipsilateral pattern found in the Interphone study and is one of the strongest arguments for biological specificity in the association.
Acoustic neuroma also elevated. In addition to glioma, the Hardell data showed elevated acoustic neuroma (vestibular schwannoma) risk with long-term use — the same tumor type seen in the heart in the NTP and Ramazzini animal studies (both are Schwann cell tumors from different anatomical locations).
Why latency matters so much: Brain tumors have multi-decade latency periods. The current generation of heavy mobile phone users — people who adopted smartphones in the 2000s and have used them for 20+ years — are only now entering the latency window where tumors would become detectable. The Hardell data, collected from the early-adopter generation, may be showing the front edge of a wave that current exposure levels will amplify.

The Aires Perspective: Why Hardell’s Work Matters for Precautionary Action

The Hardell dose-response finding — more use equals more risk, with a 25+ year latency window — argues directly for precautionary action now, before the next wave of long-term epidemiological data becomes available. By the time a 25-year cohort of smartphone-native users reaches statistical significance, the exposure accumulation will be irreversible. Aires structural field modulation technology is designed for exactly this situation: an established possible carcinogen, a dose-response signal, and a multi-decade latency window that makes waiting for certainty the worst risk-management strategy available. Explore the Aires research corpus →

Dose-response. Ipsilateral dominance. 25-year latency. The Hardell data is the human evidence of what NTP showed in animals.

Shop Aires Products →

Frequently Asked Questions

What did the Hardell 2013 study find about mobile phones and brain tumors?

The Hardell study found a dose-dependent increased glioma risk with long-term mobile phone use, with the highest risk in people reporting 25+ years of use (approximately 2-fold elevated). The risk was strongest for tumors on the same side of the head as the dominant phone ear. A similar pattern was found for acoustic neuromas (vestibular schwannomas). Both tumor types are consistent with the schwannoma findings in the NTP and Ramazzini animal studies.

Is the Hardell research credible?

Lennart Hardell is a practicing oncologist and cancer researcher who published his first case-control study of mobile phones and brain tumors in 1999. He has consistently used the same methodology across multiple studies, allowing for pooled analysis of increasingly large datasets. His studies have been peer-reviewed and published in respected journals. He receives no industry funding. His methodology has been reviewed and accepted by the IARC Working Group that issued the 2B classification.

Why do some studies not find the Hardell association?

Studies with shorter follow-up periods (under 10 years) typically find no significant association — consistent with the Hardell finding that the risk elevation becomes significant only at longer latency (10–25+ years). Industry-funded studies and studies using shorter latency windows consistently show weaker associations than independent studies with longer follow-up. This differential disappears in the 25+ year latency group, where even some industry-adjacent studies show elevated risk.

What is the significance of ipsilateral tumor location?

Finding brain tumors more often on the same side of the head as phone use is strong evidence of anatomical specificity — meaning the exposure location matters, which is inconsistent with a chance association or with a systemic non-specific carcinogen effect. The ipsilateral finding has been replicated in the Interphone study and is one of the most compelling aspects of the Hardell epidemiological data.

The EMF Landmark Research Series

→ Full series overview: The EMF Research You Need to Know

Tags: Acoustic Neuroma, Brain Tumor, EMF Research, Epidemiology, Glioma, Hardell 2013, Landmark Studies, Long-Term Risk